Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

909 UV Digester – Get Rid of Organic Matter in your Samples Fast!

Published: Thursday, March 21, 2013
Last Updated: Thursday, March 21, 2013
Bookmark and Share
Metrohm presents the 909 UV Digester, a new digestion unit for sample preparation by UV photolysis.

The 909 UV Digester enables simultaneous digestion of up to 12 samples and excels by its robust design and short digestions times. It is recommeded for voltammetric and spectroscopic methods, where organic matter present in the sample interferes with the determination of the the heavy metal analytes.

Digestion of samples in the 909 UV Digester is fully automatic. The centerpiece of the digester isMetrohm_210313.gif a UV lamp that provides the necessary UV radiation. The heat generated by the lamp is dissipated via an air-cooling system. To ensure that digestion takes place under controlled conditions, a Pt1000 temperature sensor is used to measure the digestion temperature in a reference sample. An integral microprocessor controls the digestion temperature and the digestion time.

Standards that recommend sample preparation by UV photolysis include:

•    DIN 38406, Part 16: Determination of zinc, cadmium, lead, copper, thallium, nickel, cobalt by voltammetry
•    DIN 38406, Part 17: Determination of uranium – Method using adsorptive stripping voltammetry in surface water, raw water and drinking water

UV digestion is suitable for transparent samples with low-to-medium organic contamination (up to approx. 100 mg carbon/L). The classical application field for UV digestion is processing of all types of water samples, e.g. surface waters or wastewaters. However, liquid biological samples (e.g. urine) or foods (e.g. juices and alcoholic beverages) too can be digested using an adapted procedure.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos